Ron Martell, Chief Executive Officer at PONIARD PHARMACEUTICALS, INC. (PARD), bought 12,115 shares at $1.26 ($15K) on 2010-03-25, disclosed to the SEC on 2010-03-29.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.24 | 10,915 | $14K | 90.0% |
| 2 | $1.26 | 1,200 | $2K | 10.0% |
| Total | $1.24 avg | 12,115 | $15K | 100% |
| Filing → |
| IMCL | SELL | 2006-04-14 | $184K | — | Filing → |